Technivie is a once daily antiviral combination medication once used with ribavirin for the treatment of type 4 hepatitis C. It is no longer available and has been replaced by newer antiviral combination medications.
| Common Brands | Technivie |
|---|---|
| Drug Class | Antiviral Combo |
| Controlled Substance Classification | Not a controlled medication |
| Generic Status | No lower-cost generic available |
| Availability | Discontinued |
Prescription savings
Stop paying too much for your prescriptions. Compare prices, get pharmacy coupons, and save up to 80%.
Find expert answers to your health questions so you can make the best decisions for yourself and your family.Health conditions
Medications & treatment
Access & affordability
Our monthly healthcare membership can help you save thousands on your prescription costs.Resources
Technivie, a combination of two antiviral medications (ombitasvir, paritaprevir) and a booster medication (ritonavir), was used to treat hepatitis C type 4. The typical regimen was two tablets in the morning with a meal, in combination with another antiviral medication, ribavirin, for 12 weeks.
No, there are no brand or generic versions available in the U.S.
Providers didn't prescribe Technivie as often after new and improved oral medications became available. The newer agents don't need to be taken with ribavirin. As a result, the manufacturer stopped making the medication due to a lack of demand.
